Literature DB >> 4891824

Opipramol and trifluoperazine in the treatment of anxiety and tension.

J M Barritt, B W McGuinness, G Beaumont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4891824      PMCID： PMC2236886     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN： 0035-8797


× No keyword cloud information.
  7 in total

1.  A PILOT TRIAL OF G. 33040 IN THE TREATMENT OF DEPRESSIVE ILLNESS.

Authors:  L G KILOH; J R ROY; M W CARNEY
Journal:  J Neuropsychiatr       Date:  1963-10

2.  The effects of G-33040 in depressive states: a multi-blind study.

Authors:  H AZIMA; A SILVER; D ARTHURS
Journal:  Am J Psychiatry       Date:  1962-11       Impact factor: 18.112

3.  Trifluoperazine in psychoneurotic outpatients.

Authors:  E S GODDARD
Journal:  Can Med Assoc J       Date:  1959-09-15       Impact factor: 8.262

4.  Evaluation of a tranquilizer in general practice.

Authors:  A L KOLODNY
Journal:  Dis Nerv Syst       Date:  1961-03

5.  The treatment of psychoneurotic conditions with trifluoperazine.

Authors:  G BRAM
Journal:  Br J Clin Pract       Date:  1960-02

6.  A clinical evaluation of opipramol (Ensidon) in the treatment of anxious depression.

Authors:  J E KIRKHAM; J KINROSS-WRIGHT
Journal:  Psychosomatics       Date:  1962 Nov-Dec       Impact factor: 2.386

7.  Treatment of psychoneurotic conditions with long acting trifluoperazine (stelazine), spansule capsules.

Authors:  G BRAN
Journal:  Br J Clin Pract       Date:  1962-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.